Literature DB >> 16482217

Structural basis for the inhibition of activin signalling by follistatin.

Adrian E Harrington1, Samantha A Morris-Triggs, Brandon T Ruotolo, Carol V Robinson, Shin-Ichi Ohnuma, Marko Hyvönen.   

Abstract

The secreted, multidomain protein follistatin binds activins with high affinity, inhibiting their receptor interaction. We have dissected follistatin's domain structure and shown that the minimal activin-inhibiting fragment of follistatin is comprised of the first and second Fs domains (Fs12). This protein can bind to activin dimer and form a stable complex containing two Fs12 molecules and one activin dimer. We have solved crystal structures of activin A alone and its complex with Fs12 fragment to 2 A resolution. The complex structure shows how Fs12 molecules wrap around the back of the 'wings' of activin, blocking the type II receptor-binding site on activin A. Arginine 192 in Fs2 is a key residue in this interaction, inserting itself in between activin's fingers. Complex formation imposes a novel orientation for the EGF- and Kazal-like subdomains in the Fs2 domain and activin A shows further variation from the canonical TGF-beta family fold. The structure provides a detailed description of the inhibitory mechanism and gives insights into interactions of follistatin with other TGF-beta family proteins.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16482217      PMCID: PMC1409725          DOI: 10.1038/sj.emboj.7601000

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  53 in total

1.  Follistatin: essential role for the N-terminal domain in activin binding and neutralization.

Authors:  Y Sidis; A L Schneyer; P M Sluss; L N Johnson; H T Keutmann
Journal:  J Biol Chem       Date:  2001-03-14       Impact factor: 5.157

2.  wARP: improvement and extension of crystallographic phases by weighted averaging of multiple-refined dummy atomic models.

Authors:  A Perrakis; T K Sixma; K S Wilson; V S Lamzin
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1997-07-01

3.  T7 vectors with modified T7lac promoter for expression of proteins in Escherichia coli.

Authors:  J Peränen; M Rikkonen; M Hyvönen; L Kääriäinen
Journal:  Anal Biochem       Date:  1996-05-01       Impact factor: 3.365

4.  The dorsalizing and neural inducing gene follistatin is an antagonist of BMP-4.

Authors:  A Fainsod; K Deissler; R Yelin; K Marom; M Epstein; G Pillemer; H Steinbeisser; M Blum
Journal:  Mech Dev       Date:  1997-04       Impact factor: 1.882

5.  The organizer factors Chordin and Noggin are required for mouse forebrain development.

Authors:  D Bachiller; J Klingensmith; C Kemp; J A Belo; R M Anderson; S R May; J A McMahon; A P McMahon; R M Harland; J Rossant; E M De Robertis
Journal:  Nature       Date:  2000-02-10       Impact factor: 49.962

Review 6.  Follistatin-related protein (FSRP): a new member of the follistatin gene family.

Authors:  A Schneyer; D Tortoriello; Y Sidis; H Keutmann; T Matsuzaki; W Holmes
Journal:  Mol Cell Endocrinol       Date:  2001-06-30       Impact factor: 4.102

7.  Dorsoventral patterning in Xenopus: inhibition of ventral signals by direct binding of chordin to BMP-4.

Authors:  S Piccolo; Y Sasai; B Lu; E M De Robertis
Journal:  Cell       Date:  1996-08-23       Impact factor: 41.582

8.  Identification and characterization of a novel follistatin-like protein as a binding protein for the TGF-beta family.

Authors:  K Tsuchida; K Y Arai; Y Kuramoto; N Yamakawa; Y Hasegawa; H Sugino
Journal:  J Biol Chem       Date:  2000-12-29       Impact factor: 5.157

9.  Crystal structure of BMP-9 and functional interactions with pro-region and receptors.

Authors:  Monica A Brown; Qinghai Zhao; Kent A Baker; Chethana Naik; Cecil Chen; Laurie Pukac; Mallika Singh; Tatiana Tsareva; Yanick Parice; Angela Mahoney; Viktor Roschke; Indra Sanyal; Senyon Choe
Journal:  J Biol Chem       Date:  2005-04-25       Impact factor: 5.157

10.  Functional analysis of activins during mammalian development.

Authors:  M M Matzuk; T R Kumar; A Vassalli; J R Bickenbach; D R Roop; R Jaenisch; A Bradley
Journal:  Nature       Date:  1995-03-23       Impact factor: 49.962

View more
  70 in total

1.  Characterization of follistatin-type domains and their contribution to myostatin and activin A antagonism.

Authors:  Jennifer N Cash; Elizabeth B Angerman; Henry T Keutmann; Thomas B Thompson
Journal:  Mol Endocrinol       Date:  2012-05-16

Review 2.  The structures that underlie normal reproductive function.

Authors:  Thomas F Lerch; Min Xu; Theodore S Jardetzky; Kelly E Mayo; Ishwar Radhakrishnan; Ralph Kazer; Lonnie D Shea; Teresa K Woodruff
Journal:  Mol Cell Endocrinol       Date:  2006-11-30       Impact factor: 4.102

3.  Characterization of the structural features and interactions of sclerostin: molecular insight into a key regulator of Wnt-mediated bone formation.

Authors:  Vaclav Veverka; Alistair J Henry; Patrick M Slocombe; Andrew Ventom; Barbara Mulloy; Frederick W Muskett; Mariusz Muzylak; Kevin Greenslade; Adrian Moore; Li Zhang; Jianhua Gong; Xueming Qian; Chris Paszty; Richard J Taylor; Martyn K Robinson; Mark D Carr
Journal:  J Biol Chem       Date:  2009-02-10       Impact factor: 5.157

Review 4.  Structural Biology and Evolution of the TGF-β Family.

Authors:  Andrew P Hinck; Thomas D Mueller; Timothy A Springer
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-12-01       Impact factor: 10.005

Review 5.  Specificity, versatility, and control of TGF-β family signaling.

Authors:  Rik Derynck; Erine H Budi
Journal:  Sci Signal       Date:  2019-02-26       Impact factor: 8.192

6.  Structural characterization of an activin class ternary receptor complex reveals a third paradigm for receptor specificity.

Authors:  Erich J Goebel; Richard A Corpina; Cynthia S Hinck; Magdalena Czepnik; Roselyne Castonguay; Rosa Grenha; Angela Boisvert; Gabriella Miklossy; Paul T Fullerton; Martin M Matzuk; Vincent J Idone; Aris N Economides; Ravindra Kumar; Andrew P Hinck; Thomas B Thompson
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-17       Impact factor: 11.205

Review 7.  Follistatin as potential therapeutic target in prostate cancer.

Authors:  Maria Vittoria Sepporta; Francesca Maria Tumminello; Carla Flandina; Marilena Crescimanno; Marco Giammanco; Maurizio La Guardia; Danila di Majo; Gaetano Leto
Journal:  Target Oncol       Date:  2013-03-01       Impact factor: 4.493

8.  Members of the DAN family are BMP antagonists that form highly stable noncovalent dimers.

Authors:  Chandramohan Kattamuri; David M Luedeke; Kristof Nolan; Scott A Rankin; Kenneth D Greis; Aaron M Zorn; Thomas B Thompson
Journal:  J Mol Biol       Date:  2012-10-09       Impact factor: 5.469

9.  Activin signaling as an emerging target for therapeutic interventions.

Authors:  Kunihiro Tsuchida; Masashi Nakatani; Keisuke Hitachi; Akiyoshi Uezumi; Yoshihide Sunada; Hiroshi Ageta; Kaoru Inokuchi
Journal:  Cell Commun Signal       Date:  2009-06-18       Impact factor: 5.712

10.  Activin/Nodal inhibition alone accelerates highly efficient neural conversion from human embryonic stem cells and imposes a caudal positional identity.

Authors:  Rickie Patani; Alastair Compston; Clare A Puddifoot; David J A Wyllie; Giles E Hardingham; Nicholas D Allen; Siddharthan Chandran
Journal:  PLoS One       Date:  2009-10-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.